Abstract
Natural antimicrobial peptides (AMPs) are gene-coded defense molecules discovered in all the three life domains: Eubacteria, Archaea, and Eukarya. The latter covers protists, fungi, plants, and animals. It is now recognized that amino acid composition, peptide sequence, and post-translational modifications determine to a large extent the structure and function of AMPs. This article systematically describes post-translational modifications of natural AMPs annotated in the antimicrobial peptide database (http://aps.unmc.edu/AP). Currently, 1147 out of 1755 AMPs in the database are modified and classified into more than 17 types. Through chemical modifications, the peptides fold into a variety of structural scaffolds that target bacterial surfaces or molecules within cells. Chemical modifications also confer desired functions to a particular peptide. Meanwhile, these modifications modulate other peptide properties such as stability. Elucidation of the relationship between AMP property and chemical modification inspires peptide engineering. Depending on the objective of our design, peptides may be modified in various ways so that the desired features can be enhanced whereas unwanted properties can be minimized. Therefore, peptide design plays an essential role in developing natural AMPs into a new generation of therapeutic molecules.
Keywords: Chemical modification, database, peptide selectivity, peptide stability, peptide engineering, structural diversity, Natural antimicrobial peptides, multi-enzyme systems, hydrophobic, D-Amino Acids, Halogenation (Br or Cl), Hydroxylation, Terminal Capping, Oxidation
Current Biotechnology
Title: Post-Translational Modifications of Natural Antimicrobial Peptides and Strategies for Peptide Engineering
Volume: 1 Issue: 1
Author(s): Guangshun Wang
Affiliation:
Keywords: Chemical modification, database, peptide selectivity, peptide stability, peptide engineering, structural diversity, Natural antimicrobial peptides, multi-enzyme systems, hydrophobic, D-Amino Acids, Halogenation (Br or Cl), Hydroxylation, Terminal Capping, Oxidation
Abstract: Natural antimicrobial peptides (AMPs) are gene-coded defense molecules discovered in all the three life domains: Eubacteria, Archaea, and Eukarya. The latter covers protists, fungi, plants, and animals. It is now recognized that amino acid composition, peptide sequence, and post-translational modifications determine to a large extent the structure and function of AMPs. This article systematically describes post-translational modifications of natural AMPs annotated in the antimicrobial peptide database (http://aps.unmc.edu/AP). Currently, 1147 out of 1755 AMPs in the database are modified and classified into more than 17 types. Through chemical modifications, the peptides fold into a variety of structural scaffolds that target bacterial surfaces or molecules within cells. Chemical modifications also confer desired functions to a particular peptide. Meanwhile, these modifications modulate other peptide properties such as stability. Elucidation of the relationship between AMP property and chemical modification inspires peptide engineering. Depending on the objective of our design, peptides may be modified in various ways so that the desired features can be enhanced whereas unwanted properties can be minimized. Therefore, peptide design plays an essential role in developing natural AMPs into a new generation of therapeutic molecules.
Export Options
About this article
Cite this article as:
Wang Guangshun, Post-Translational Modifications of Natural Antimicrobial Peptides and Strategies for Peptide Engineering, Current Biotechnology 2012; 1 (1) . https://dx.doi.org/10.2174/2211550111201010072
DOI https://dx.doi.org/10.2174/2211550111201010072 |
Print ISSN 2211-5501 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-551X |
Call for Papers in Thematic Issues
Age Reversal using transient epigenetc reprogramming with the OSK Yamanaka Factors
Aging is a complex biological process characterized by a gradual deterioration of physiological functions and an increased vulnerability to disease. Recent advancements in the field of regenerative medicine have shown promising avenues for combating aging. Among these, partial epigenetic reprogramming, specifically utilizing the Yamanaka factors, has been shown to reverse ...read more
Bioinformatic Analysis of Regulated Cell Death in Chronic and Acute Inflammatory Diseases
In the intricate realm of inflammatory diseases, delving into the complexities surrounding regulated cell death emerges as an indispensable and forefront area of exploration. Understanding the intricacies of how cells are regulated to undergo death in inflammatory conditions not only represents a pivotal frontier in biomedical research but also holds ...read more
Feeding a vegan World
The Eat-Lancet Planetary diet recommends at least 2/3 plant and microbial sources in the food protein portion. Such diet is recommended against obesity, cancer and to limit global warming, and might get more and more incentives in the next years. We thus need massive amounts of Plant-based food, and the ...read more
Leveraging AI for personalized pediatric neurodevelopmental support
Personalized medicine in pediatrics is a moving target dedicated to finding the right treatment, at the right time, for each individual child in each stage of development. Child development is a highly personal process, unique to each individual, something which is even more apparent in the development of children with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bioactive Peptides: Potential Impact on the Treatment of Gastrointestinal
Cancers
Current Pharmaceutical Design Flavonoids: A Review of Its Commercial Application Potential as Anti- Infective Agents
Current Medicinal Chemistry - Anti-Infective Agents Editorial (Thematic Issue: Targeting Anti-Cancer Agents and Cancer Treatments)
Anti-Cancer Agents in Medicinal Chemistry NAD+ Metabolism and NAD+-Dependent Enzymes: Promising Therapeutic Targets for Neurological Diseases
Current Drug Targets Mechanism of Cancer Drug Resistance and the Involvement of Noncoding RNAs
Current Medicinal Chemistry Importance of Kier-Hall Topological Indices in the QSAR of Anticancer Drug Design
Current Computer-Aided Drug Design Exploring Confluence-Related Signalling to Modulate the Expression of Oct4 – A Role in Facilitating Mouse Somatic Cell Reprogramming?
Current Stem Cell Research & Therapy DNA Repair Proteins as Molecular Targets for Cancer Therapeutics
Anti-Cancer Agents in Medicinal Chemistry Recent Development of Anticancer Therapeutics Targeting Akt
Recent Patents on Anti-Cancer Drug Discovery Potassium Channels: Novel Emerging Biomarkers and Targets for Therapy in Cancer
Recent Patents on Anti-Cancer Drug Discovery Chemical and Potential Biological Perspectives of Genus Sarcococca (Buxaceae)
The Natural Products Journal Effects of Hypoxia and Ischemia on MicroRNAs in the Brain
Current Medicinal Chemistry Angiogenesis as a Therapeutic Target in Arthritis: Lessons from Oncology
Current Pharmaceutical Design <i>In Silico</i> Study of Potential Cross-Kingdom Plant MicroRNA Based Regulation in Chronic Myeloid Leukemia
Current Pharmacogenomics and Personalized Medicine Vaccination Against Angiogenesis-Associated Antigens: A Novel Cancer Immunotherapy Strategy
Current Molecular Medicine Computational Approaches for Predicting Causal Missense Mutations in Cancer Genome Projects
Current Bioinformatics Double Strand Break Repair Activities of p53 as Potential Tumor Suppressor Function Counteracting Mammary Tumor Development
Current Women`s Health Reviews Enhancing the Site-Specific Targeting of Macromolecular Anticancer Drug Delivery Systems
Current Drug Targets CDC25 Phosphatase Inhibitors: An Update
Mini-Reviews in Medicinal Chemistry Hydroxamate, a Key Pharmacophore Exhibiting a Wide Range of Biological Activities
Mini-Reviews in Medicinal Chemistry